NCT05494632

Brief Summary

Interaural loudness and pitch mismatch in single-sided deaf cochlear implant (SSD-CI) recipients reduces binaural processing cues and contributes to performance outcomes, specifically speech understanding in noise and localization. The study aims to improve binaural cues through speech processor program modifications that reduce interaural mismatches.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 8, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 10, 2022

Completed
2 days until next milestone

Study Start

First participant enrolled

August 12, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2024

Completed
11 months until next milestone

Results Posted

Study results publicly available

July 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

March 23, 2026

Status Verified

March 1, 2026

Enrollment Period

2 years

First QC Date

August 8, 2022

Results QC Date

March 17, 2025

Last Update Submit

March 9, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Speech Understanding in Noise, Measured With the R-Space Test Environment. The R-Space Test Environment Simulates Speech Understanding in a Noisy Restaurant.

    Participants speech understanding was evaluated in the R-Space test environment with two speech processor programs, an everyday or default program and a modified program. The modified program was created to reduce interaural frequency or loudness mismatch between participants' CI ear and normal hearing ear. The R-Space simulates listening in a noisy restaurant, a real-world listening situation. The score is a signal-to-noise ratio that reflects 50% speech understanding in noise. Participants are surrounded by 8 loudspeakers with restaurant noise from all 8. A sentence is presented from the front loudspeaker. Participants repeat back what they hear. The noise is adjusted adaptively. For a correct response, the noise is increased; it is decreased for an incorrect response. This provides signal-to-noise ratio (SNR) for 50% speech understanding. The average score for participants with normal hearing is -5 dB SNR. A lower number represents better performance than a higher number.

    Participants were tested in the R-Space twice with each speech processor program, e.g., everyday or default program and modified program. The testing was carried out within a 2-3 month time period, and after using each program for at least 6 weeks.

Study Arms (3)

Period 1: Study 1

EXPERIMENTAL

CI speech processor programming in experienced cochlear implant (CI) recipients with single sided deafness. Program changes were made to decrease the interaural frequency mismatch between the CI ear and the contralateral ear.

Device: Treatment-modifications to CI speech processor program. Specifically reducing interaural frequency mismatch in experienced SSD-CI recipients.

Period 2: Study 2

EXPERIMENTAL

CI speech processor programming in newly implanted cochlear implant (CI) recipients with single sided deafness. Program changes were made to decrease the interaural frequency mismatch between the CI ear and the contralateral ear.

Device: Treatment-modifications to CI speech processor program to reduced interaural frequency mismatch in newly implanted SSD-CI recipients.

Period 3: study 3

EXPERIMENTAL

CI speech processor programming in experienced cochlear implant (CI) recipients with single sided deafness. Program changes were made to decrease the interaural loudness mismatch between the CI ear and the contralateral ear.

Device: Treatment-modifications to CI speech processor program to reduced interaural loudness mismatch in experienced SSD-CI recipients.

Interventions

We will modify the CI speech processor program to reduce interaural loudness mismatch between the CI ear and the contralateral ear in experienced CI recipients with SSD.

Period 3: study 3

We will modify the CI speech processor program to reduce interaural frequency mismatch between the CI ear and the contralateral ear in newly implanted CI recipients with SSD.

Period 2: Study 2

We will modify the CI speech processor program to reduce interaural frequency mismatch between the CI ear and the contralateral ear in experienced CI recipients with SSD.

Period 1: Study 1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants for the proposed study will be adults with single-sided deafness. Participants will have at least 6 months experience with their cochlear implant or will be newly implanted with the cochlear implant.
  • years of age and older
  • Postlingual onset of SSD
  • Pure tone average (PTA) at 500, 1000, and 2000 Hz of less than or equal to 30 dB HL in the contralateral ear, known as the normal hearing ear
  • Implanted with or chosen to be implanted with a Nucleus cochlear implant
  • Full insertion of electrode array

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location

Limitations and Caveats

One of the limitations was the small number of SSD participants in the trial.

Results Point of Contact

Title
Jill B Firszt, PhD
Organization
Washington University School of Medicine

Study Officials

  • Jill B Firszt, PhD

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 8, 2022

First Posted

August 10, 2022

Study Start

August 12, 2022

Primary Completion

July 30, 2024

Study Completion

August 1, 2025

Last Updated

March 23, 2026

Results First Posted

July 1, 2025

Record last verified: 2026-03

Locations